{{Drugbox
| IUPAC_name = methyl (2''S'')-2-({1-[(4-fluorophenyl)methyl]-1''H''-indol-3-yl}formamido)-3,3-dimethylbutanoate
| image = MDMB_FUBICA.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category =  
| legal_AU = 
| legal_CA = Schedule II
| legal_UK = PSA
| legal_US = 
| legal_status = Illegal in Sweden
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 1971007-91-6
| ATC_prefix =  
| ATC_suffix =  
| PubChem =  
| ChemSpiderID      = 57621561
| smiles            = COC(=O)[C@@H](NC(=O)c1cn(Cc2ccc(F)cc2)c3ccccc13)C(C)(C)C
| StdInChI          = 1S/C23H25FN2O3/c1-23(2,3)20(22(28)29-4)25-21(27)18-14-26(19-8-6-5-7-17(18)19)13-15-9-11-16(24)12-10-15/h5-12,14,20H,13H2,1-4H3,(H,25,27)/t20-/m1/s1
| StdInChIKey       = RVAWIZIGOSKPBP-HXUWFJFHSA-N

<!--Chemical data-->
| C=23 | H=25 | F=1 | N=2 | O=3
| molecular_weight =
}}

'''MDMB-FUBICA''' is an [[indole]]-based [[synthetic cannabinoid]] that is presumed to be a potent [[agonist]] of the [[CB1 receptor|CB<sub>1</sub> receptor]] and has been sold online as a [[designer drug]].

It was first detected by the [[European Monitoring Centre for Drugs and Drug Addiction|EMCDDA]] in Sweden in February 2015.<ref>{{cite web | url=http://drogfokuszpont.hu/wp-content/uploads/NFP_hirlevel_2015_majus.pdf | title=HAMAROSAN: 2015. ÉVI EURÓPAI KÁBÍTÓSZER - JELENTÉS | publisher=Hungarian National Focal Point (NFP) | date=June 2015 | accessdate=23 July 2015}}</ref>

== Side effects ==

MDMB-FUBICA's indazole analogue [[MDMB-FUBINACA]] has been linked to at least 1000 hospitalisations and 40 deaths as a consequence of intoxication as of March 2015.<ref>{{cite web | url=http://www.fskn.gov.ru/includes/periodics/news/2015/0317/205035975/detail.shtml | title=Очередная жертва спайса | publisher=Federal Drug Control Service of the Russian Federation | date=17 March 2015 | accessdate=24 July 2015}}</ref>

== Legality ==

MDMB-FUBICA is banned in Sweden.<ref>{{cite web | url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/juni/23-nya-amnen-kan-klassas-som-narkotika-eller-halsofarlig-vara/ | title=23 nya ämnen kan klassas som narkotika eller hälsofarlig vara | publisher=Folkhälsomyndigheten | date=1 June 2015 | accessdate=24 July 2015}}</ref>

==See also==
{{div col|colwidth=30em}}
* [[5F-AB-PINACA]]
* [[5F-ADB]]
* [[5F-AMB]]
* [[5F-APINACA]]
* [[AB-FUBINACA]]
* [[AB-CHFUPYCA]]
* [[AB-CHMINACA]]
* [[AB-PINACA]]
* [[ADB-CHMINACA]]
* [[ADB-FUBINACA]]
* [[ADB-PINACA]]
* [[AMB-FUBINACA]]
* [[APINACA]]
* [[APP-FUBINACA]]
* [[FUB-APINACA]]
* [[MDMB-CHMICA]]
* [[MDMB-CHMINACA]]
* [[PX-3]]
{{Div col end}}

==References==
{{reflist}}

{{Cannabinoids}}

[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Indolecarboxamides]]
[[Category:Fluoroarenes]]


{{cannabinoid-stub}}